HDV-Insulin Lispro Cuts Hypoglycemia in Phase 2b Type 1 Diabetes Trial
Hepatocyte-directed vesicle technology positions the delivery platform at the intersection of pharma and advanced nutra…
Hepatocyte-directed vesicle technology positions the delivery platform at the intersection of pharma and advanced nutra…
Results published simultaneously in NEJM and Nature Medicine signal a new mechanistic benchmark for metabolic-health fo…
With BHB blends flooding e-commerce channels, operators and formulators face mounting pressure to substantiate ketone-d…
As the men's wellness segment expands, operators and formulators face tightening expectations around evidence-based pos…
Early-phase data presented at EULAR 2026 positions B-cell depletion as a credible mechanism in autoimmune disease manag…
As the metabolic health ingredient space watches GLP-1 mimetic botanicals gain shelf space, pharma-grade peptide data c…
Biomea Fusion also flags muscle-preservation and fat-reduction signals, positioning the menin inhibitor as a potential …
The episode underscores persistent industry pressure to back cognitive structure-function claims with peer-reviewed cli…
As GLP-1 weight-loss agents reshape the metabolic health market, lean-mass retention emerges as a key functional differ…
As honey-matrix delivery formats gain shelf space in the nootropic category, regulators and consumers alike are pressin…
Findings from the first decentralized, real-world HD chorea study surface patient- and caregiver-reported outcomes — a …
Olive polyphenols are gaining formulation traction as dual-certification positioning signals cleaner-label credibility …